Patents by Inventor Anastasia V. Lipatova

Anastasia V. Lipatova has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
    Publication number: 20220088098
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Application
    Filed: December 6, 2021
    Publication date: March 24, 2022
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar
  • OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
    Publication number: 20220088097
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Application
    Filed: December 6, 2021
    Publication date: March 24, 2022
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar
  • Optimized oncolytic viruses and uses thereof
    Patent number: 11253558
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: February 22, 2022
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar
  • DELIVERY OF ONCOLYTIC VIRUSES USING DENDRITIC CELLS
    Publication number: 20200352993
    Abstract: A versatile carrier system for systemic delivery of oncolytic viruses comprises dendritic cells having at least one oncolytic virus loaded therein. It is believed that the dendritic cells will protect the oncolytic virus(es) against neutralizing antibodies, can transport the oncolytic virus(es) to targeted tumor locations, and then deliver virions to the tumor locations.
    Type: Application
    Filed: May 7, 2020
    Publication date: November 12, 2020
    Inventors: Peter M. Chumakov, Darya A. Berzhitskaya, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar
  • OPTIMIZED ONCOLYTIC VIRUSES AND USES THEREOF
    Publication number: 20180085411
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Application
    Filed: September 27, 2017
    Publication date: March 29, 2018
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar